Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

AstraZeneca has formed a collaboration with the gene-sequencing company, Illumina, Inc., to develop its next generation sequencing (NGS) platform for companion diagnostic tests applicable across AstraZeneca's oncology portfolio. AstraZeneca...

Gamida Cell, a Jerusalem-based developer of stem-cell technologies and therapeutic products, has signed an investment and option agreement with Novartis Pharma AG, under which Novartis will invest $35 million in Gamida Cell and in...

AstraZeneca reports it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with Brilinta (ticagrelor), the company's drug to treat acute coronary syndrome. The...

Pfizer Inc. has completed the submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for palbociclib, an oral drug to treat advanced breast cancer. The FDA has a 60-day filing review period to determine whether...

Biogen Idec reports that the US Food and Drug Administration (FDA) has approved Plegridy (peginterferon beta-1a), a new treatment for people with relapsing forms of multiple sclerosis (RMS). Plegridy is a pegylated beta interferon approved for use...

Roche reports that the US Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of women with persistent, recurrent or metastatic carcinoma...